Market Cap (In CAD)
10.83 Million
Revenue (In CAD)
-
Net Income (In CAD)
-1.27 Million
Avg. Volume
94.49 Thousand
- Currency
- CAD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.015-0.03
- PE
- -
- EPS
- -
- Beta Value
- 0.909
- ISIN
- CA74141E1043
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Stephen Van Deventer
- Employee Count
- -
- Website
- https://www.preveceutical.com
- Ipo Date
- 2017-01-11
- Details
- PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.
More Stocks
-
RECY-BRecyctec Holding AB ser. B
RECY-B
-
7561
-
GGGSYGreggs plc
GGGSY
-
ANGHAnghami Inc.
ANGH
-
6829
-
XBITXBiotech Inc.
XBIT
-
89988
-
KONMYKonami Group Corporation
KONMY